REFERENCES
- Ainbinder D j, Barrett G H, Tellado M. Hydroxyapatite orbital implant absess: Histopathologic correlation of an infected implant following evisceration. Ophthalmic Plast Reconstr Surg 1994; 10: 267–270
- Bigham W J, Stanley P, Cahill J M, et al. Fibrovascular in growth in porous ocular implants: The effect of material composition, porosity, growth factors and coatings. Ophthalmic Plast Reconstr Surg 1999; 15: 317–325
- Buettner H, Bartely G B. Tissue breakdown and exposure associated with orbital hyroxyapatite implants. Am J Ophthalmol 1992; 113: 669
- Chalasani R, Poole-Warren L, Conway R M, Ben-Nissan B. Porous orbital implants in Enucleation: A systematic review. Surv Ophthalmol 2007; 52: 145–155
- Choi H Y, Lee S J, Park J H, Oum B S, et al. Magnetic resonance imaging assessment of fibrovascular ingrowth into porous polyethylene orbital implants. Clin Experiment Ophthalmol 2006; 34: 354–359
- Civelek A C, Pacheco E M, Natrajan T K, et al. Quantitative measurement of vascularization and vascular ingrowth rate of coralline hydroxyapatite ocular implant by Tc-99m MDP bone imaging. Clin Nucl Med 1995; 20: 779–787
- De Potter P, Duprez T, Cosnard G. Postcontrast magnetic resonance imaging assessment of porous polyethylene orbital implant (Medpor). Ophthalmology 2000; 107: 1656–1660
- De Potter P, Shields C L, Shields J A, et al. Role of Magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant. Ophthalmology 1992; 99: 824–830
- Dutton J J. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991; 98: 370–377
- Flanders A E, De Potter P, Rao V M, et al. MRI of orbital hydroxyapatite implants. Neuroradiology 1996; 38: 273–277
- Glatt H. Exposed hydroxyapatite implants. Ophthalmology 1995; 104: 528–529
- Inkster C F, Ng S GJ, Leatherbarrow B JM. Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology 2002; 109: 389–392
- Jordan D R, Brownstein S, Dorey M, Ho Yuen V, Gilberg S. Fibrovascularization of Porous Polyethylene (Medpor) orbital implant in a rabbit model. Ophthal Plast Reconstr Surg 2004; 20: 136–143
- Jordan D R, Brownstein S, Faraji H. Clinicopathological analysis of 15 explanted hydroxyapatite implants. Ophthal Plast Reconstr Surg 2004; 20: 285–290
- Jordan D R, Klapper S R, Gilberg S M. The use of vicryl mesh in 200 porous orbital implants: a technique with few exposures. Ophthal Plast Reconstr Surg 2003; 19: 53–61
- Kadyan A, Sandramouli S. Porous polyethylene (Medpor) orbital implants with primary acellular dermis patch grafts. Orbit 2008; 27: 19–23
- Karcioglu Z A, Al-Mesfer S A, Mullaney P. Porous polyethylene orbital implant in patients with retinoblastoma. Ophthalmology 1998; 105: 1311–1316
- Karesh J W, Dresner S C. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994; 101: 1688–1696
- Klapper S R, Jordan D R, Ells A, Grahovac S. Hydroxyapatite orbital implant vascularization assessed by magnetic resonance imaging. Ophthal Plast Reconstr Surg. 2003; 19: 46–52
- Mawn L A, Jordan D R, Gilberg S. Scanning electron microscopic examination of porous orbital implants. Can J Ophthalmol 1998; 33: 203–209
- Nunery W R, Heinz G W, Bonnin J M, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993; 9: 96–104
- Patel P J, Rees H C, Olver J M. Fibrovacularization of porous polyethylene orbital floor implants. Arch Ophthalmol 2003; 121: 400–403
- Remulla H D, Rubin P AD, Shore J W, Sutula F C, et al. Complications of porous spherical orbital implants. Ophthalmology 1995; 102: 586–592
- Rosner M, Edward D P, Tso M O. Foreign-body giant-cell reaction to the hydroxyapatite orbital implant. Arch Ophthalmol 1992; 110: 173–174
- Rubin P AD, Popham J K, Bilyk J R, Shore J W. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994; 10: 96–103
- Sagoo M S, Olver J M. Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure. Br J Ophthalmol 2004; 88: 942–946
- Saitoh A, et al. Histologic study of living response to artificially synthesized hydroxyapatite implant: 1-year follow-up. Plast Reconstr Surg 1996; 98: 706–710
- Sekundo W, Seifert P. Hydroxyapatite orbital Implant. A light and electron-microscopic and immunohistochemical study. Ophthalmology 1998; 105: 539–543
- Shields C L, Shields J A, De Potter P, Singh A D. Problems with hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 1994; 78: 702–706
- Shields C L, Shields J A, Eagle R C, De Potter P. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol 1991; 111: 363–366
- Shorr N, Perry J D, Goldberg R A, Hoenig J, Shorr J. The safety and applications of acellular human dermal allograft in ophthalmic plastic and reconstructive surgery: a preliminary report. Ophthal Plast Reconstr Surg 2000; 16: 223–230
- Thakker M M, Fay M A, Pieroth L, Rubin P AD. Fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants wrapped with acellular dermis. Ophthal Plast Reconstr Surg 2004; 20: 368–373